Please ensure Javascript is enabled for purposes of website accessibility Contrarian Fund - Janus Henderson Investors - US Advisor
For Financial Professionals in the US

Contrarian Fund Holdings

Full Portfolio Holdings

(As of 11/30/2024)

% OF INVESTMENTS
Oracle Corp 5.31
Vertiv Holdings Co 5.11
Caesars Entertainment Inc 5.06
Surgery Partners Inc 4.19
Intercontinental Exchange Inc 4.15
Marvell Technology Inc 4.10
Western Alliance Bancorp 4.05
Capital One Financial Corp 4.04
PNC Financial Services Group Inc 3.91
Amazon.com Inc 3.76
Chart Industries Inc 3.66
UnitedHealth Group Inc 3.34
Sempra 2.87
Dell Technologies Inc 2.80
Advanced Micro Devices Inc 2.55
Argenx SE (ADR) 2.45
Taiwan Semiconductor Manufacturing Co Ltd (ADR) 2.39
Globus Medical Inc 2.34
Howmet Aerospace Inc 2.28
Monster Beverage Corp 2.15
3M Co 2.02
Madrigal Pharmaceuticals Inc 2.01
Workday Inc 1.95
Freeport-McMoRan Inc 1.95
Teleflex Inc 1.80
Signet Jewelers Ltd 1.61
Galderma Group AG 1.56
Occidental Petroleum Corp 1.53
Core & Main Inc 1.45
Sotera Health Co 1.44
Hong Kong Exchanges & Clearing Ltd 1.29
Crown Holdings Inc 1.25
Cullen/Frost Bankers Inc 1.23
Lantheus Holdings Inc 1.16
Vaxcyte Inc 1.14
Sportradar Group AG 1.00
Constellium SE 0.98
Ferguson Enterprises Inc/DE 0.93
Beauty Health Co, 1.25%, 10/01/26 0.77
AbbVie Inc 0.52
HubSpot Inc 0.50
AST SpaceMobile Inc 0.34
Beauty Health Co 0.29
DELL US 20Dec24 Call (AMERICAN PHYSICAL) MS OTC 180 0.00
WDAY US 20Dec24 Call (AMERICAN PHYSICAL) BAML OTC 310 0.00
CZR US 20Dec24 Put (AMERICAN PHYSICAL) GS OTC 32 0.00
ASTS US 21Feb25 Call (AMERICAN PHYSICAL) BAML OTC 50 0.00
ORCL US 20Dec24 Call (AMERICAN PHYSICAL) JPM OTC 220 0.00
VRT US 20Dec24 Call (AMERICAN PHYSICAL) GS OTC 150 -0.01
Cash & Equivalents 0.78
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.